A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients
| Autor: | Zinzani, P.L. *, Tani, M., Fanti, S., Stefoni, V., Musuraca, G., Castellucci, P., Marchi, E., Farsad, M., Fina, M., Pellegrini, C., Alinari, L., Derenzini, E., de Vivo, A., Bacci, F., Pileri, S., Baccarani, M. |
|---|---|
| Zdroj: | In Annals of Oncology April 2008 19(4):769-773 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|